Immuthera
Phase 1Developing novel, First-in-Class CD6/CTLA-4 CAR-Tregs for Type 1 Diabetes, Dermatological, and Neuroinflammatory Autoimmune Diseases.
Founded
1913
Focus
Cell & Gene Therapy
About
Developing novel, First-in-Class CD6/CTLA-4 CAR-Tregs for Type 1 Diabetes, Dermatological, and Neuroinflammatory Autoimmune Diseases.
Funding History
2Total raised: $3.7M
Grant$1.2MPolish National Centre for Research and DevelopmentAug 15, 2021
Seed$2.5MUndisclosedNov 15, 2020
Company Info
TypePrivate
Founded1913
LocationWarsaw, Poland
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
AILIS Breast Cancer
Pre-clinical · Warsaw
Biocam
Pre-clinical · Warsaw
Bioton
Pre-clinical · Warsaw
Ensera
Pre-clinical · Warsaw
Biovico
Pre-clinical · Warsaw
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile